The Rise and Fall in Premarket: Analyzing Top Movers Today

Shares of Taysha Gene Therapies, Inc. TSHA surged in pre-market trading after the company delivered favorable FY23 EPS results.

In the fiscal year 2023, Taysha reported losses of 96 cents per share, a significant improvement from the $3.78 per share loss in the previous year. The company also disclosed a strong cash position of $143.9 million as of Dec. 31, 2023.

Additionally, Taysha Gene Therapies announced progress in its clinical trials, with the completion of dosing in cohort one of the REVEAL Phase 1/2 trial, expansion into the U.S., and site activation initiation in Canada.

Taysha Gene Therapies shares experienced a notable 27.1% uptick to $2.86 in pre-market trading.

Here is a look at other stocks making moves in pre-market trading.

Winners

• ETAO International Co., Ltd. ETAO shares soared 200.4% to $0.4296 in early trading after announcing a reverse stock split.
• Oblong, Inc. OBLG climbed 48.2% to $0.20 pre-market following a robust financial report for Q4 2023.
• BYND Cannasoft Enterprises Inc. BCAN gained 44% to $0.0288 in pre-market, rebounding from a 15% decline the previous day. The company engaged Aegis Capital for a $7.0 million public offering.
• Mangoceuticals, Inc. MGRX rose 40.5% to $0.2698 in pre-market trading following a 4% increase on Tuesday.
• EZFill Holdings Inc. EZFL surged 18% to $1.90 pre-market, recovering from a 9% decline the previous day.
• SCWorx Corp. WORX jumped 16.9% to $3.32 in pre-market trading following a substantial 54% surge on Tuesday.
• BitFuFu Inc. FUFU shares advanced 11.7% to $6.03 pre-market after a 32% gain on Tuesday.
• Canopy Growth Corporation CGC rose 14.4% to $4.38 in pre-market trading. VP Kamala Harris recently advocated for the rescheduling of marijuana by the DEA.
• Getty Images Holdings, Inc. GETY saw a 14% increase to $5.36 pre-market. Getty Images reported upbeat Q4 revenue and issued positive FY24 revenue guidance.

Losers

• Ontrak, Inc. OTRK dropped 20.5% to $0.35 pre-market after a sharp 131% increase on Tuesday.
• Momentus Inc. MNTS fell 19.1% to $0.4803 pre-market, reversing gains made following a US patent grant on Tuesday.
• Aquestive Therapeutics, Inc. AQST declined 14.8% to $4.55 in pre-market trading after pricing its $75 million public offering at $4.50 per share.
• Verb Technology Company, Inc. VERB fell 14.2% to $0.3309 pre-market following a 7% surge on Tuesday. The company recently expanded its Market.live social shopping integration.
• Harrow, Inc. HROW slid 14.6% to $9.09 pre-market after underperforming in Q4 results.
• NuScale Power Corporation SMR tumbled 6.8% to $6.13 pre-market, following a 35% drop on Tuesday post a Wells Fargo downgrade and price target reduction.
• CERo Therapeutics Holdings, Inc. CERO decreased 6.4% to $2.25 pre-market after a 14% increase on Tuesday.
• Clearmind Medicine Inc. CMND shares dipped 6.2% to $1.21 pre-market. The company received divisional patent approval in China on Tuesday.
• MaxCyte, Inc. MXCT shares fell 5.8% to $4.20 pre-market after a 7% rise on Tuesday. MaxCyte reported strong Q4 results and issued positive FY24 guidance recently.
• Society Pass Incorporated SOPA saw a 5% decline to $0.1456 in pre-market.

Now Read This: Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday